U.S. markets open in 42 minutes
  • S&P Futures

    3,605.75
    +29.75 (+0.83%)
     
  • Dow Futures

    29,882.00
    +336.00 (+1.14%)
     
  • Nasdaq Futures

    11,950.50
    +45.25 (+0.38%)
     
  • Russell 2000 Futures

    1,844.30
    +27.20 (+1.50%)
     
  • Crude Oil

    43.68
    +0.62 (+1.44%)
     
  • Gold

    1,802.70
    -35.10 (-1.91%)
     
  • Silver

    23.05
    -0.59 (-2.49%)
     
  • EUR/USD

    1.1871
    +0.0025 (+0.21%)
     
  • 10-Yr Bond

    0.8720
    +0.0150 (+1.75%)
     
  • Vix

    21.57
    -2.13 (-8.99%)
     
  • GBP/USD

    1.3333
    +0.0010 (+0.08%)
     
  • USD/JPY

    104.5500
    +0.0620 (+0.06%)
     
  • BTC-USD

    19,153.75
    +701.79 (+3.80%)
     
  • CMC Crypto 200

    378.49
    +17.06 (+4.72%)
     
  • FTSE 100

    6,411.46
    +77.62 (+1.23%)
     
  • Nikkei 225

    26,165.59
    +638.22 (+2.50%)
     

CLASS ACTION UPDATE for BMRN, BTU and LRN: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

·4 min read

NEW YORK, NY / ACCESSWIRE / November 20, 2020 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the court. Further details about the cases can be found at the links provided. There is no cost or obligation to you.

BMRN Shareholders Click Here: https://www.zlk.com/pslra-1/biomarin-pharmaceutical-inc-loss-submission-form?prid=11123&wire=1
BTU Shareholders Click Here: https://www.zlk.com/pslra-1/peabody-energy-corporation-loss-submission-form?prid=11123&wire=1
LRN Shareholders Click Here: https://www.zlk.com/pslra-1/k12inc-information-request-form?prid=11123&wire=1

* ADDITIONAL INFORMATION BELOW *

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)

BMRN Lawsuit on behalf of: investors who purchased February 28, 2020 - August 18, 2020
Lead Plaintiff Deadline: November 24, 2020
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/biomarin-pharmaceutical-inc-loss-submission-form?prid=11123&wire=1

According to the filed complaint, during the class period, BioMarin Pharmaceutical Inc. made materially false and/or misleading statements and/or failed to disclose that: (i) differences between the Phase 1/2 and Phase 3 study of valoctocogene roxaparvovec, an investigational adenoassociated virus gene therapy, limited the reliability of the Phase 1/2 study to support valoctocogene roxaparvovec's durability of effect; (ii) as a result, it was foreseeable that the U.S. Food and Drug Administration would not approve the Biologics License Application for valoctocogene roxaparvovec without additional data; and (iii) as a result, the Company's public statements were materially false and misleading at all relevant times.

Peabody Energy Corporation (NYSE:BTU)

BTU Lawsuit on behalf of: investors who purchased April 3, 2017 - October 28, 2019
Lead Plaintiff Deadline: November 27, 2020
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/peabody-energy-corporation-loss-submission-form?prid=11123&wire=1

According to the filed complaint, during the class period, Peabody Energy Corporation made materially false and/or misleading statements and/or failed to disclose that: (a) the Company had failed to implement adequate safety controls at the North Goonyella mine to prevent the risk of a spontaneous combustion event; (b) the Company failed to follow its own safety procedures; (c) as a result, the North Goonyella mine was at a heightened risk of shutdown; (d) the Company's low-cost plan to restart operations at the mine posed unreasonable safety and environmental risks; (e) The Australian body responsible for ensuring acceptable health and safety standards, the Queensland Mines Inspectorate, would likely mandate a safer, cost-prohibitive approach; and (f) as a result, there would be major delays in reopening the North Goonyella mine and restarting coal production.

K12 Inc. (NYSE:LRN)

LRN Lawsuit on behalf of: investors who purchased April 27, 2020 - September 18, 2020
Lead Plaintiff Deadline: January 19, 2021
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/k12inc-information-request-form?prid=11123&wire=1

According to the filed complaint, during the class period, K12 Inc. made materially false and/or misleading statements and/or failed to disclose that: (i) K12 lacked the technological capabilities, infrastructures, and expertise to support the increased demand for virtual and blended education necessitated by the global pandemic; (ii) K12 lacked adequate cyberattack protocols and protections to prevent the disabling of its computer system; (iii) K12 was unable provide the necessary levels of administrative support and training to teachers, students, and parents; and (iv) based on the foregoing, Defendants lacked a reasonable basis for their positive statements about the Company's business, operations, and prospects and/or lacked a reasonable basis and omitted facts.

You have until the lead plaintiff deadlines to request that the court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

Levi & Korsinsky is a nationally recognized firm with offices in New York, California, Connecticut, and Washington D.C. The firm's attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
55 Broadway, 10th Floor
New York, NY 10006
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com

SOURCE: Levi & Korsinsky, LLP



View source version on accesswire.com:
https://www.accesswire.com/617820/CLASS-ACTION-UPDATE-for-BMRN-BTU-and-LRN-Levi-Korsinsky-LLP-Reminds-Investors-of-Class-Actions-on-Behalf-of-Shareholders